Status of large-scale analysis of post-translational modifications by mass spectrometry.
Olsen JV, Mann M. · 2013
Read Status of large-scale analysis of post-translational modifications by mass spectrometry. by Olsen JV, Mann M. (2013) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3861698.txt.
Introduction
Jesper V. Olsen and Matthias Mann take stock of protein modification mapping in Molecular & Cellular Proteomics in 2013. Cells tune proteins with chemical add-ons after the proteins are built. Mass spectrometry can now find those add-ons across the whole protein stock at once, a leap of the past decade.
For the main add-on types, labs can now pin down tens of thousands of sites with trust, and can compare levels between cell states. New work even gauges what share of each protein copy bears a mark. Software to sift the flood of sites has kept pace. Yet no add-on type has a full site list, and none is near one soon. The overview marks both the gains and the open ground for this special journal issue.
Catalog record
| CREATOR | Olsen JV, Mann M. |
|---|---|
| YEAR | 2013 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 50 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Status of Large-scale Analysis of Post-translational Modifications by Mass Spectrometry* By Jesper V Olsen, Matthias Mann Published in: Molecular & Cellular Proteomics : MCP DOI: 10.1074/mcp.O113.034181 ABSTRACT Abstract Cellular function can be controlled through the gene expression program, but often protein post-translational modifications (PTMs) provide a more precise and elegant mechanism. Key functional roles of specific modification events—for instance, during the cell cycle—have been known for decades, but only in the past 10 years has mass-spectrometry-(MS)-based proteomics begun to reveal the true extent of the PTM universe. In this overview for the special PTM issue of Molecular and Cellular Proteomics, we take stock of where MS-based proteomics stands in the large-scale analysis of protein modifications. For many PTMs, including phosphorylation, ubiquitination, glycosylation, and acetylation, tens of thousands of sites can now be confidently identified and localized in the sequence of the protein. The quantification of PTM levels between different cellular states is likewise established, with label-free methods showing particular promise. It is also becoming possible to determine the absolute occupancy or stoichiometry of PTM sites on a large scale. Powerful software for the bioinformatic analysis of thousands of PTM sites has been developed. However, a complete inventory of sites has not been established for any PTM, and this situation will persist into the foreseeable future. Furthermore, although PTM coverage by MS-based methods is impressive, it still needs to be improved, especially in tissues and in clinically relevant systems. The central challenge for the field is to develop streamlined methods for determining biological functions for the myriad of modifications now known to exist. The human genome project has revealed a surprisingly small number of protein-coding genes: around 20,000—not many more than those of the lowly worm (1). In contrast, it has turned out that there is a bewildering number and diversity of RNA species, and biological functions for many of them are still not known. Proteins constitute the next level of the gene expression program, and here diversity comes in two forms: variants affecting the primary sequence of amino acids, and post-translational modifications (PTMs).1 Today primary sequence variation is mainly studied indirectly by means of deep RNA sequencing, although top-down and shotgun proteomics could provide more direct and quantitative results in the future (2). In contrast, the unbiased discovery and analysis of large numbers of PTM sites is the exclusive domain of MS-based proteomics, and great strides are being made in identifying the myriad possible protein modifications. The study of PTMs via MS now constitutes a large and vibrant field of research, as exemplified in the original and review papers in this special issue of Molecular and Cellular Proteomics. Here we provide a snapshot of where the field stands, what progress has already been made, and where we see the key challenges for the future. PTM Analysis via MS Mass spectrometry has long been used to map modifications on purified proteins; in fact, this was one of the first applications of MS in protein research (3). In contrast, proteomic investigations of PTMs—meaning their analysis on a large number of proteins, such as those in an organelle or in an entire cell—have taken off only since the beginning of the past decade (4–6). Although the obstacles to complete proteome analysis are finally being overcome (7), this is not the case for PTMs, because their analysis is more difficult both technologically and conceptually. There are several principal differences between proteome and PTM analysis. In proteome measurements, several peptides are generally available to characterize each protein, which makes the measurement much more robust, whereas in PTM measurements each peptide representing a modification site of interest needs to stand on its own. Modified peptides can be of lower abundance and more difficult to identify from their fragmentation spectra than nonmodified peptides. Furthermore, these tandem mass spectra should contain sufficient information to localize the modification with single amino acid resolution. Below we address the challenges of the PTM workflow in turn (Fig. 1). [Figure: Overview of PTM analysis and challenges. The principal steps in the workflow for PTM analysis are depicted on the left. On the right, the main types of modifications, alternative proteases, PTM enrichment methods, and quantification types are symbolized. For each step, some of the main challenges are listed.] Extraction, Solubilization, and Digestion The sample preparation methods used for PTM analysis are generally the same as for standard shotgun proteomics. Exceptions are the PTM enrichment step and the strict requirement to inactivate enzymes responsible for adding or removing the PTM of interest. The extraction and solubilization of proteins from cell culture lysates is relatively straightforward, and a number of robust protocols exist. In contrast, more effort should be directed toward the efficient retrieval of proteins from tissues with high contents of extracellular matrix. As an example, cardiac muscle tissue is very rigid, and special homogenization technologies are needed to efficiently extract proteins for enrichment of their phosphopeptides (8). Chromatin-bound and transmembrane proteins are easily analyzed in proteome studies, but they are still challenging in PTM analysis, as the enrichment strategies might not be compatible with the specific buffers applied (9) and peptides from all parts of the proteins need to be generated. As in expression proteomics, trypsin is the protease of choice for PTM analysis because of its high cleavage specificity (10) and the MS/MS-friendly properties of the resulting peptides. In some instances tryptic peptides might be too small or too large for LC-MS/MS analysis, a fact that needs to be taken into account when certain critical PTM sites need to be quantified in planned experiments. Likewise, some PTMs modify the solubility properties of the peptides significantly. For example, glycosylated or phosphorylated tryptic peptides can be too hydrophilic to be captured by conventional reversed-phase C18 material. Using proteases with different cleavage specificities such as chymotrypsin, Lys-N, or endoproteinase Glu-C (11, 12) in addition to trypsin can help one overcome some of these issues and should be more broadly considered. Developments in these areas are often underappreciated, but they are critical to the overall success of PTM-based proteomics. Enrichment and Sensitivity in PTM Analysis Regulatory PTMs, by definition, have substoichiometric occupancy of their target proteins, making it a major challenge to achieve sensitivity in MS analysis (Fig. 1). Although proteomics workflows have become much more sensitive overall, they still require a specific step in which the PTM of interest is enriched with respect to the unmodified proteins or peptides. There are now protocols with very high specificity for phosphorylated peptides, often leading to a phosphopeptide proportion of more than 90%. Enrichment efficiency can be around a factor of 100, making it possible to start with much more protein material than in proteome analysis and thereby boosting sensitivity (13). However, the fact that these starting amounts are much greater than what is needed for proteome analysis needs to be considered in PTM-based projects. Metal affinity chromatography—for instance, using titanium dioxide (14)—and/or anti-phosphotyrosine antibodies (15) are frequently employed. It is also possible to enrich with antibodies raised against specific phosphorylation motifs, but generally it is more attractive to analyze the entire phosphoproteome instead. With a few exceptions such as N-linked glycopeptide enrichment via lectins (16), the specificity and enrichment for other PTMs are much lower. The